Keiju Aokage

14PUBLICATIONS
45CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)OtorhinolaryngologyOral and maxillofacial surgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 05, 2026
Function-preserving radical surgery for early-stage non-small cell lung cancer: A review of limited resection approaches.

Yoichi Ohtaki, Keiju Aokage, Tomohiro Miyoshi

|Jul 23, 2025
Long-term survival outcome after surgical resection of pulmonary neuroendocrine tumors.

Eisuke Goto, Keiju Aokage, Kotaro Nomura

|Oct 25, 2024
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1-Positive NSCLC: A Phase II Trial (EAST ENERGY).

Keiju Aokage, Shohei Koyama, Shogo Kumagai

|Aug 19, 2024
The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: outstanding contribution and entering a new phase.

Kazuo Nakagawa, Masaya Yotsukura, Takahiro Mimae

|Nov 12, 2023
Rare but clinically important salivary gland-type tumor of the lung: A review.

Shinkichi Takamori, Yasushi Yatabe, Atsushi Osoegawa

Pageof 3